MYDA Advisors’s Guardant Health GH Stock Holding History

MYDA Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8,000	Closed	-$511K	–	129
2019 Q3	$511K	Buy	+8,000	New	+$705K	0.23%	64

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MYDA Advisors's GH Position: Q2 2020 in Review

MYDA Advisors sold out of Guardant Health (GH) in Q2 2020, closing a stake of 4,400 shares — an estimated $306K sold.

MYDA Advisors first reported a position in GH in Q1 2019 and held it in 4 quarters. The position peaked at $4.08M in Q4 2019. 324 funds tracked by Wall St. Rank hold GH as of Q2 2020.

MYDA Advisors reported no remaining Guardant Health position as of Q2 2020 after selling out during the quarter.
MYDA Advisors sold 4,400 Guardant Health shares in Q2 2020, an estimated $306K.
MYDA Advisors first reported a position in Guardant Health in Q1 2019 and held it in 4 quarters.
MYDA Advisors's Guardant Health position peaked at $4.08M in Q4 2019.
324 funds tracked by Wall St. Rank held Guardant Health as of Q2 2020.

Based on MYDA Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.